| ²é¿´: 292 | »Ø¸´: 3 | ||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | ||
| ¡¾ÐüÉͽð±Ò¡¿»Ø´ð±¾ÌûÎÊÌ⣬×÷Õß½ðÁÛstone½«ÔùËÍÄú 8 ¸ö½ð±Ò | ||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||
½ðÁÛstoneľ³æ (ÕýʽдÊÖ)
|
[ÇóÖú]
[ÇóÖúÈ¡Ïû]ÎÄÏ×һƪ
|
|
|
¡¾È«ÎÄÁ´½Ó»òÊý¾Ý¿âÃû³Æ£¨pubmed µã»÷¡°linkout¡±£©¡¿ http://www.ncbi.nlm.nih.gov/pubmed/9511454?dopt=Abstract °æÖ÷²»ºÃÒâʶ£¬ÎÒÔÚÎÄÏ×ÇóÖú°æ·¢µÄʱºòһֱ˵À´Â·²»ÕýÈ·£¬·¢²»ÁË£¬Ö»ÄÜÔÚÕâÌṩÁ´½ÓÇóÖúÁË [ Last edited by ½ðÁÛstone on 2008-1-19 at 18:01 ] |
» ²ÂÄãϲ»¶
281Çóµ÷¼Á£¨0805£©
ÒѾÓÐ12È˻ظ´
Ò»Ö¾Ô¸Î÷ÄϽ»´ó£¬Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
0854¿É¿çµ÷¼Á£¬Ò»×÷Ò»ÏîºËÐÄÂÛÎÄÎåÏîרÀû£¬Ê¡¡¢¹ú¼¶Ö¤Êé40+ÊýÒ»Ó¢Ò»287
ÒѾÓÐ7È˻ظ´
297Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
²ÄÁÏר˶306Ó¢Ò»Êý¶þ
ÒѾÓÐ13È˻ظ´
0703»¯Ñ§µ÷¼Á £¬Áù¼¶Òѹý£¬ÓпÆÑоÀú
ÒѾÓÐ10È˻ظ´
0817 »¯Ñ§¹¤³Ì 299·ÖÇóµ÷¼Á ÓпÆÑоÀú ÓжþÇøÎÄÕÂ
ÒѾÓÐ6È˻ظ´
ÊÕ¸´ÊÔµ÷¼ÁÉú
ÒѾÓÐ4È˻ظ´
²ÄÁÏר˶274Ò»Ö¾Ô¸ÉÂÎ÷ʦ·¶´óѧÇóµ÷¼Á
ÒѾÓÐ6È˻ظ´
331Çóµ÷¼Á£¨0703Óлú»¯Ñ§
ÒѾÓÐ8È˻ظ´
xjxlovelxl
ÈÙÓþ°æÖ÷ (ÖªÃû×÷¼Ò)
CA-FANS
- ²©Ñ§EPI: 7
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ¹ó±ö: 2.962
- ½ð±Ò: 1168
- É¢½ð: 5254
- ºì»¨: 3
- Ìû×Ó: 5985
- ÔÚÏß: 116Сʱ
- ³æºÅ: 291151
- ×¢²á: 2006-10-28
- ÐÔ±ð: MM
- רҵ: ѪҺϵͳ¼²²¡ÕïÁÆÐ¼¼Êõ
- ¹ÜϽ: Óн±ÎÊ´ð

4Â¥2008-01-17 10:42:36
mymuchong207
½ð³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 1304.9
- Ìû×Ó: 1643
- ÔÚÏß: 3.4Сʱ
- ³æºÅ: 474287
- ×¢²á: 2007-12-05
- ÐÔ±ð: GG
- רҵ: ²ÄÁÏ
2Â¥2008-01-17 10:35:34
¸ß¸ß978
ͳæ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 182
- Ìû×Ó: 86
- ÔÚÏß: 1.8Сʱ
- ³æºÅ: 478446
- ×¢²á: 2007-12-14
- רҵ: Ô˳ïÓë¹ÜÀí
¡ï ¡ï
½ðÁÛstone(½ð±Ò+2,VIP+0):xiexie
½ðÁÛstone(½ð±Ò+2,VIP+0):xiexie
|
±êÌâ: Analysis of selected diphosphonic acid derivatives used in treatment of osteoporosis. Part I. Complexometric determination of diphosphonic acid derivatives. ×÷Õß: Podolska M; Białecka W; Kwiatkowska-Puchniarz B; Tuszy¨½ska E Author's Address: Drug Institute, Warsaw, Poland. À´Ô´: Acta Poloniae Pharmaceutica [Acta Pol Pharm] 1997 Jul-Aug; Vol. 54 (4), pp. 267-72. ³ö°æÎïÀàÐÍ: Journal Article ÓïÑÔ: English Journal Information: Country of Publication: POLAND NLM ID: 2985167R Publication Model: Print Cited Medium: Print ISSN: 0001-6837 (Print) Subsets: MEDLINE MeSH ´ÊÓï: Diphosphonates/*analysis Titrimetry/*methods Alendronate/analysis; Analgesics, Non-Narcotic/analysis; Clodronic Acid/analysis; Diphosphonates/chemistry; Etidronic Acid/analysis; Osteoporosis/drug therapy ÕªÒª: The purpose of the study was to develop a simple method for determination of diphosphonic acid derivatives in pharmaceutical preparations used in treatment of osteoporosis: disodium etidronate, disodium clodronate, disodium tiludronate, disodium pamidronate, sodium alendronate. The analysis performed by the visual end point titration method with complexing reagent Th(DCTA) in presence of xylenol orange used the ability of these compounds to form complexes. CAS Registry Number: 0 (Analgesics, Non-Narcotic) 0 (Diphosphonates) 10596-23-3 (Clodronic Acid) 2809-21-4 (Etidronic Acid) 40391-99-9 (pamidronate) 66376-36-1 (Alendronate) 89987-06-4 (tiludronic acid) ÌõÄ¿ÈÕÆÚ: Date Created: 19980420 Date Completed: 19980420 Latest Revision: 20060308 ¸üдúÂë: 20071207 PMID: 9511454 ´Ë¼Ç¼µÄÓÀ¾ÃÁ´½Ó: http://search.epnet.com/login.as ... 1454&lang=zh-cn Êý¾Ý¿â£º MEDLINE |
3Â¥2008-01-17 10:36:53













»Ø¸´´ËÂ¥
50